Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



WELCH DANIEL G Create: Alert

All | News | Filings
Date FiledTypeDescription
08/04/2023 4 WELCH DANIEL G (Director) has filed a Form 4 on Structure Therapeutics Inc.
Txns: Disposed of 411,000 options to buy @ $2.6, valued at $1.1M
Acquired 205,500 options to buy @ $2.6, valued at $534.3k
Acquired 205,500 options to buy @ $2.6, valued at $534.3k
06/09/2023 4 WELCH DANIEL G (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 3,860 shares @ $0
Granted 7,110 options to buy @ $51.82, valued at $368.4k
06/02/2023 4 WELCH DANIEL G (Director) has filed a Form 4 on Seagen Inc.
Txns: Granted 2,044 shares @ $0
05/17/2023 4 WELCH DANIEL G (Director) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 366,744 options to buy @ $1.64, valued at $601.5k
05/16/2023 4 WELCH DANIEL G (Director) has filed a Form 4 on Seagen Inc.
Txns: Sold 1,864 shares @ $200.02, valued at $372.8k
Exercised 1,864 options to buy @ $135.63, valued at $252.8k
05/03/2023 4 WELCH DANIEL G (Director) has filed a Form 4 on Seagen Inc.
Txns: Sold 5,150 shares @ $200.04, valued at $1M
Sold 1,990 shares @ $200.12, valued at $398.2k
Sold 295 shares @ $200.06, valued at $59k
Sold 4,890 shares @ $200.06, valued at $978.3k
Sold 1,888 shares @ $200.05, valued at $377.7k
Sold 3,171 shares @ $200.05, valued at $634.4k
Sold 3,462 shares @ $200.1, valued at $692.7k
Sold 351 shares @ $200.07, valued at $70.2k
Sold 5,835 shares @ $200.07, valued at $1.2M
Exercised 1,990 options to buy @ $56.77, valued at $113k
Exercised 5,150 options to buy @ $64.38, valued at $331.6k
04/05/2023 4 WELCH DANIEL G (Director) has filed a Form 4 on Seagen Inc.
Txns: Sold 995 shares @ $200.11, valued at $199.1k
Sold 5,680 shares @ $200.71, valued at $1.1M
Sold 3,575 shares @ $201.59, valued at $720.7k
Sold 5 shares @ $202.49, valued at $1k
Sold 7,158 shares @ $202.51, valued at $1.4M
Sold 112 shares @ $203.05, valued at $22.7k
Sold 817 shares @ $200.45, valued at $163.8k
Sold 851 shares @ $201.51, valued at $171.5k
Sold 1,082 shares @ $202.54, valued at $219.1k
Sold 3,124 shares @ $200.45, valued at $626.2k
Sold 3,317 shares @ $201.51, valued at $668.4k
03/17/2023 4 WELCH DANIEL G (Director) has filed a Form 4 on Seagen Inc.
Txns: Sold 2,037 shares @ $200.05, valued at $407.5k
Sold 320 shares @ $200.05, valued at $64k
Sold 1,246 shares @ $200.05, valued at $249.3k
Exercised 2,037 options to buy @ $38.82, valued at $79.1k
03/16/2023 4 WELCH DANIEL G (Director) has filed a Form 4 on Seagen Inc.
Txns: Sold 283 shares @ $202.36, valued at $57.3k
Sold 1,348 shares @ $201.53, valued at $271.7k
Sold 7,629 shares @ $200.3, valued at $1.5M
Sold 2,098 shares @ $200.2, valued at $420k
Sold 214 shares @ $201.53, valued at $43.1k
Sold 44 shares @ $202.35, valued at $8.9k
Sold 74 shares @ $200, valued at $14.8k
Sold 470 shares @ $200, valued at $94k
Sold 5,758 shares @ $200.06, valued at $1.2M
Sold 8,210 shares @ $200.2, valued at $1.6M
Sold 808 shares @ $201.53, valued at $162.8k
02/09/2023 4 WELCH DANIEL G (Director) has filed a Form 4 on Structure Therapeutics Inc.
Txns: Converted 123,508 shares @ $0
Converted 123,508 options to buy @ $0
06/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2022 4 WELCH DANIEL G (Director) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 118,784 options to buy @ $4.05, valued at $481.1k
05/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/02/2021 4 WELCH DANIEL G (Director) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 45,229 options to buy @ $9.17, valued at $414.7k
06/28/2021 4 WELCH DANIEL G (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 2,145 shares @ $0
Granted 4,125 options to buy @ $93.2, valued at $384.5k
05/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/12/2021 4 WELCH DANIEL G (Director) has filed a Form 4 on Nuvation Bio Inc.
Txns: Granted 86,184 options to buy @ $4.6, valued at $396.4k
Granted 312,750 options to buy @ $1.74, valued at $544.2k
11/04/2020 4 WELCH DANIEL G (Director) has filed a Form 4 on Seagen Inc.
Txns: Sold 8,750 shares @ $168.24, valued at $1.5M
Sold 8,750 shares @ $167.34, valued at $1.5M
Sold 7,982 shares @ $166.7, valued at $1.3M
Sold 9,518 shares @ $165.72, valued at $1.6M
Sold 14,500 shares @ $165.06, valued at $2.4M
Sold 9,250 shares @ $164.61, valued at $1.5M
Exercised 14,500 options to buy @ $19.02, valued at $275.8k
Exercised 7,982 options to buy @ $20.06, valued at $160.1k
Exercised 9,518 options to buy @ $20.06, valued at $190.9k
Exercised 8,750 options to buy @ $34.25, valued at $299.7k
Exercised 8,750 options to buy @ $36.7, valued at $321.1k
06/30/2020 4 WELCH DANIEL G (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 2,550 shares @ $0
Granted 4,250 options to buy @ $76.58, valued at $325.5k
06/01/2020 4 WELCH DANIEL G (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Granted 1,595 shares @ $0
Granted 2,966 options to buy @ $72.74, valued at $215.7k
05/19/2020 4 WELCH DANIEL G (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Granted 1,335 shares @ $0
Granted 3,171 options to buy @ $160.33, valued at $508.4k
05/07/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/09/2020 4 WELCH DANIEL G (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Exercised 17,500 options to buy @ $12.76, valued at $223.3k
06/21/2019 4 WELCH DANIEL G (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Granted 1,570 shares @ $0
Granted 2,174 options to buy @ $82.25, valued at $178.8k
06/13/2019 4 WELCH DANIEL G (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 3,000 shares @ $0
Granted 5,000 options to buy @ $58.74, valued at $293.7k
05/22/2019 4 WELCH DANIEL G (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Granted 2,963 shares @ $0
Granted 7,038 options to buy @ $64.38, valued at $453.1k
06/22/2018 4 WELCH DANIEL G (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns: Granted 1,787 shares @ $0
Granted 2,748 options to buy @ $85.12, valued at $233.9k
06/20/2018 4 WELCH DANIEL G (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.
Txns: Granted 3,000 shares @ $0
Granted 5,000 options to buy @ $80.69, valued at $403.5k
05/22/2018 4 WELCH DANIEL G (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Granted 3,700 shares @ $0
Granted 9,260 options to buy @ $56.77, valued at $525.7k
03/30/2018 4 WELCH DANIEL G (Director) has filed a Form 4 on AveXis, Inc.
Txns: Granted 1,106 shares @ $0
Granted 2,905 options to buy @ $133.8, valued at $388.7k
02/15/2018 4 WELCH DANIEL G (Director) has filed a Form 4 on SEATTLE GENETICS INC /WA
Txns: Exercised 6,881 options to buy @ $8.38, valued at $57.7k
Exercised 10,000 options to buy @ $10.08, valued at $100.8k
08/02/2017 4 WELCH DANIEL G (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC
Txns: Sold 602 shares @ $123.9264, valued at $74.6k
07/21/2017 4 WELCH DANIEL G (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC
Txns: Sold 217 shares @ $126.76, valued at $27.5k
06/29/2017 4 WELCH DANIEL G (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS INC
Txns: Granted 1,423 shares @ $0
Granted 2,036 options to buy @ $122.01, valued at $248.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy